Search research articles
Contact Us
Filters
Showing results (1-10 of 71) with videos related to
Page
of 8
Sort By:
Pharmacological Research
|
March 29, 2025
IUPHAR review: Computational Psychiatry 2.0. A new tool for supporting combination therapy of psychopharmacology with neuromodulation in schizophrenia
Hugo Geerts
Current Opinion in Investigational Drugs (London, England : 2000)
|
July 5, 2008
AL-108 and AL-208, formulations of the neuroprotective NAP fragment of activity-dependent neuroprotective protein, for cognitive disorders
Hugo Geerts
In Silico Pharmacology
|
December 3, 2020
Re-engineering CNS drug discovery and development using computer aided modeling
Hugo Geerts
Current Opinion in Investigational Drugs (London, England : 2000)
|
January 24, 2006
Ispronicline (Targacept)
Hugo Geerts
Therapie
|
June 18, 2004
[The virtual synapse what is its contribution to understanding cholinergic neural transmission?]
Hugo Geerts
CNS Drugs
|
October 23, 2009
Of mice and men: bridging the translational disconnect in CNS drug discovery
Hugo Geerts
Brain Research Bulletin
|
January 11, 2005
Indicators of neuroprotection with galantamine
Hugo Geerts
Idrugs : the Investigational Drugs Journal
|
February 8, 2007
Drug evaluation: (R)-flurbiprofen--an enantiomer of flurbiprofen for the treatment of Alzheimer's disease
Hugo Geerts
Drug Discovery Today
|
April 6, 2005
Small steps towards treatment of incurable neurodegenerative diseases
Hugo Geerts
Handbook of Experimental Pharmacology
|
March 20, 2025
Quantitative Systems Pharmacology Development and Application in Neuroscience
Hugo Geerts
Page
of 8
Search research articles
Search
Showing results (1-10 of 71) with videos related to
Sort By:
Page
of 8
Pharmacological Research
|
March 29, 2025
IUPHAR review: Computational Psychiatry 2.0. A new tool for supporting combination therapy of psychopharmacology with neuromodulation in schizophrenia
Hugo Geerts
Current Opinion in Investigational Drugs (London, England : 2000)
|
July 5, 2008
AL-108 and AL-208, formulations of the neuroprotective NAP fragment of activity-dependent neuroprotective protein, for cognitive disorders
Hugo Geerts
In Silico Pharmacology
|
December 3, 2020
Re-engineering CNS drug discovery and development using computer aided modeling
Hugo Geerts
Current Opinion in Investigational Drugs (London, England : 2000)
|
January 24, 2006
Ispronicline (Targacept)
Hugo Geerts
Therapie
|
June 18, 2004
[The virtual synapse what is its contribution to understanding cholinergic neural transmission?]
Hugo Geerts
CNS Drugs
|
October 23, 2009
Of mice and men: bridging the translational disconnect in CNS drug discovery
Hugo Geerts
Brain Research Bulletin
|
January 11, 2005
Indicators of neuroprotection with galantamine
Hugo Geerts
Idrugs : the Investigational Drugs Journal
|
February 8, 2007
Drug evaluation: (R)-flurbiprofen--an enantiomer of flurbiprofen for the treatment of Alzheimer's disease
Hugo Geerts
Drug Discovery Today
|
April 6, 2005
Small steps towards treatment of incurable neurodegenerative diseases
Hugo Geerts
Handbook of Experimental Pharmacology
|
March 20, 2025
Quantitative Systems Pharmacology Development and Application in Neuroscience
Hugo Geerts
Page
of 8